Molecular Diagnostics
Blood Test Predicts Treatments for Lung Cancer Patients
Traditionally, lung cancer diagnosis has relied solely on lung biopsies, an invasive procedure which many patients are too unwell to tolerate. A simple test, which can detect gene mutations in tumor DNA from blood samples, is giving new choices to lung cancer patients with faster diagnosis and improved access to life changing drugs. More...27 Sep 2017
Checklist Developed for Early Identification of Infants with SCID
Poor recognition of severe combined immune deficiency (SCID) syndrome by front-line doctors is leading to delays in diagnosis. A new testing regime aims to make diagnosis faster so that more infants with SCID, a “bubble-baby disease”, can receive life-saving treatment in time. More...26 Sep 2017
Genes behind Gestation Length and Preterm Delivery Identified
Despite evidence that genetic factors contribute to the duration of gestation and the risk of preterm birth, robust associations with genetic variants have not been identified. Preterm birth and gestational duration in general, is a complicated phenotype that is affected by both maternal and fetal genomes. More...21 Sep 2017
Combination Liquid Biopsy Diagnoses Early Cancer
Few patients with pancreatic cancer survive longer than five years, in part because most patients are identified only after their disease has progressed to an advanced stage. Most early-stage pancreatic cancers are found incidentally during an imaging scan and generally cause no symptoms. More...20 Sep 2017
Liquid Biopsy Test Launched for NRAS Mutations
The NRAS gene encodes for the N-Ras protein, which is involved in communicating signals from the exterior of the cell to the cell's interior (called signal transduction). These signals provide instructions for a cell to proliferate or differentiate. More...20 Sep 2017
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Automatic Hematology Analyzer
DH-800 Series
Clinical Chemistry System
P780
In Other News
Blood Test Predicts Immunotherapy Efficacy
Early Stage Melanoma Identified by Simple Blood Test
Direct Spectroscopy Used for Diagnosis of Neurodegenerative Disorders
Tumor Marker Levels Serve As Indicators of Disease Progression
Newly Emerged Superbug Discovered
Risk of Preeclampsia Linked to Fetal Genes
New Diagnostic Test Improves Detection of Tuberculosis
Gene Related to Abnormal Brain Development Identified
Gene Mutation Increases Risk of Neurodevelopmental Disorders
Serum Level Measurements Improve Disease Risk Prediction
Early Stage Cancer CTCs Indicators of Poor Prognosis
Antibacterial Resistance Revealed in Women with UTIs
Molecular Blood Test Could Diagnose Ischemic Stroke
Side Effects of BP Drugs Genetically Determined
Blood Test Predicts Prostate Tumor Resistance
Liquid Biopsy Panel Yields Complete Molecular Profile
Novel PCR Test Detects H. Pylori Drug Resistance
Molecular Blood Test Could Identify Alzheimer's
New Assay Facilitates Diagnosis of Rare Infant Disease
Disposable POC Device Introduced for Low-Resource Areas
Test Detects Cancer Mutations from Circulating DNA
Molecular Blood Test Developed for Kidney Cancer
Gene Expression Profiling Validated for Uveal Melanoma
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.